These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9114912

  • 21. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD, Candito M, Ferrari E, Jacomet Y, Morand P, Lapalus P.
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [Abstract] [Full Text] [Related]

  • 22. Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.
    Matsunaga K, Nakamura K, Ueda M.
    J Pharmacobiodyn; 1985 Sep; 8(9):785-7. PubMed ID: 2868089
    [Abstract] [Full Text] [Related]

  • 23. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R, Koulu M, Allonen H.
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A, Lipworth BJ.
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [Abstract] [Full Text] [Related]

  • 25. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 28. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
    Tomlinson B, Renondin JC, Graham BR, Prichard BN.
    Eur J Clin Pharmacol; 1991 Aug 26; 41(1):1-3. PubMed ID: 1685992
    [Abstract] [Full Text] [Related]

  • 29. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P, Sharma PL.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun 26; 25(6):297-300. PubMed ID: 2887519
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
    Lund-Johansen P.
    J Cardiovasc Pharmacol; 1988 Jun 26; 11 Suppl 2():S12-7. PubMed ID: 2464093
    [Abstract] [Full Text] [Related]

  • 31. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW, Sybertz EJ, Cook J, Pula K, Cedeno K, Tedesco RP, McLeod R.
    Arch Int Pharmacodyn Ther; 1989 Jun 26; 302():158-73. PubMed ID: 2576892
    [Abstract] [Full Text] [Related]

  • 32. Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
    Hedner J, Ullman A, Lemne C, Svedmyr N.
    Pulm Pharmacol; 1989 Jun 26; 2(3):155-9. PubMed ID: 2577692
    [Abstract] [Full Text] [Related]

  • 33. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH, O'Connor PC, McNeill AJ, Finch MB, Riddell JG, Shanks RG.
    Br J Clin Pharmacol; 1986 Mar 26; 21(3):249-58. PubMed ID: 2870732
    [Abstract] [Full Text] [Related]

  • 34. Effects of dilevalol on forearm circulation in essential hypertension.
    Giannattasio C, Cleroux J, Seravalle G, Grassi G, Mancia G, Zanchetti A.
    Am J Cardiol; 1989 Jun 05; 63(19):21I-24I. PubMed ID: 2567111
    [Abstract] [Full Text] [Related]

  • 35. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug 05; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 36. Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.
    Chrisp P, Goa KL.
    Drugs; 1990 Feb 05; 39(2):234-63. PubMed ID: 2184002
    [Abstract] [Full Text] [Related]

  • 37. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
    Drew GM, Hilditch A, Levy GP.
    Clin Exp Hypertens (1978); 1979 Feb 05; 1(5):597-611. PubMed ID: 42517
    [Abstract] [Full Text] [Related]

  • 38. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
    Soberman J, Greenberg S, Frishman W.
    J Clin Hypertens; 1987 Sep 05; 3(3):271-7. PubMed ID: 3312501
    [Abstract] [Full Text] [Related]

  • 39. Effects of dilevalol in the anesthetized pig with a partially occluded coronary artery.
    den Boer MO, Sassen LM, van der Giessen WJ, Saxena PR, Verdouw PD.
    Cardiovasc Drugs Ther; 1990 Dec 05; 4(6):1461-5. PubMed ID: 1981977
    [Abstract] [Full Text] [Related]

  • 40. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
    Schafers RF, Elliott HL, Howie CA, Reid JL.
    Br J Clin Pharmacol; 1991 Nov 05; 32(5):599-604. PubMed ID: 1683249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.